Publicacions en què col·labora amb Amalia Pérez Gil (6)

2022

  1. Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: A cohort study

    F1000Research, Vol. 11

  2. Guselkumab as a switching strategy after anti-TNFα, anti-IL17, or anti-IL12/23 therapies in moderate-to-severe psoriasis

    Dermatologic Therapy, Vol. 35, Núm. 10

  3. Guselkumab dosing interval optimization in adult patients with moderate-to-severe psoriasis switching from ustekinumab

    Dermatologic Therapy, Vol. 35, Núm. 11

  4. Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series

    International Journal of Dermatology, Vol. 61, Núm. 8, pp. 1029-1033

2021

  1. Guselkumab: Mid-term effectiveness, drug survival, and safety in real clinical practice

    Dermatologic Therapy, Vol. 34, Núm. 2

2020

  1. Guselkumab: Short-term effectiveness and safety in real clinical practice

    Dermatologic Therapy